Young researchers in the field of science are starting to mobilize and protest against political attacks that are affecting their ability to conduct research. Unions representing fellows at the NIH and several universities are planning protests at HHS headquarters, while grassroots groups of scientists are organizing protests in D.C. and state capitals. These researchers feel that their livelihoods are being directly impacted, prompting them to take action.
In other news, a recent survey conducted by the Pew Research Center shows that five years after the start of the Covid-19 pandemic, 56% of Americans believe that Covid-19 is no longer a significant concern. Only 4% of respondents reported wearing a mask or face covering in stores all or most of the time. The survey also revealed that opinions are divided on the level of restrictions that should have been in place during the pandemic, with 38% saying there should have been fewer restrictions, 18% saying there should have been more, and 44% saying the response was adequate.
Looking ahead, experts are concerned about the potential impact of the U.S. withdrawing from the WHO on future flu vaccines. The WHO leads the decision-making process on which specific influenza viruses the flu shot should target, and the final decision is typically made by a group that includes the CDC and FDA. However, with the U.S. government pulling out of the WHO and restricting interactions with the agency, there is uncertainty about the U.S. presence at this year’s meeting and the potential implications for next year’s flu vaccines.
Moreover, there are growing concerns about a potential brain drain in the field of biomedicine due to disruptive policies implemented by the Trump administration. Scientists and academics fear that the current political climate could drive researchers to seek opportunities overseas or leave academic research altogether. This exodus of life scientists could weaken the U.S.’s position as a global leader in biomedicine, raising alarm bells about the future of research in the country.
On a more positive note, a recent study published in JAMA Psychiatry found that people with alcohol use disorder drank less while taking Ozempic, a drug that is also used to treat obesity. Participants in the study who received Ozempic reported drinking fewer drinks at home and in controlled lab settings compared to those who received a placebo. This research highlights the potential benefits of using GLP-1 drugs like Ozempic in treating alcohol use disorder, although further studies are needed to confirm these findings.
Overall, the field of health and medicine continues to face challenges and uncertainties, but researchers and experts are working tirelessly to address these issues and find innovative solutions to improve public health outcomes. A recent victory for ‘The Angry Moms’ and clozapine users has brought hope for those with treatment-resistant psychotic disorders like schizophrenia. Clozapine, a drug with high patient-rated satisfaction and the lowest mortality among antipsychotics, has been FDA-approved for decades. However, due to serious associated side effects, there has been a requirement for patients, providers, and pharmacies to be tracked in a special registry when using the drug.
Last fall, an FDA advisory panel voted 14-1 that the registry for clozapine users was no longer necessary. This decision could be a transformative first step for mental health care, according to physician Daniel X. Pham. While the removal of the registry requirement is a positive development, it is not the only solution needed to improve mental health care.
The historically restrictive process of clozapine prescription has been a challenge for both patients and healthcare providers. The elimination of the registry could streamline the prescription process and make it more accessible to those who need it. The decision is also a win for a group known as ‘The Angry Moms’, who have been advocating for changes in the clozapine prescription process.
In other news, federal health agencies have restored webpages and datasets following a judge’s order, Medicare has removed sexual orientation and gender identity questions from enrollment forms, and there are discussions on how to close America’s life expectancy gap. Additionally, efforts are being made to attract physicians to small towns offering big perks.
Overall, the recent decision to eliminate the clozapine registry requirement is a step in the right direction for mental health care. It is a victory for ‘The Angry Moms’ and clozapine users, and it opens the door for further improvements in the treatment of psychotic disorders like schizophrenia.
